{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:26:43Z","timestamp":1792106803301,"version":"4.4.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0205600"],"award-info":[{"award-number":["2017YFA0205600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671017"],"award-info":[{"award-number":["31671017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690264"],"award-info":[{"award-number":["81690264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872809"],"award-info":[{"award-number":["81872809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.apsb.2020.11.020","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:27:03Z","timestamp":1606562823000},"page":"961-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems"],"prefix":"10.1016","volume":"11","author":[{"given":"Canyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4555-2143","authenticated-orcid":false,"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.11.020_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-pathol-011811-120856","article-title":"Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms","volume":"7","author":"Sotgia","year":"2012","journal-title":"Annu Rev Pathol: Mechanisms of Disease"},{"key":"10.1016\/j.apsb.2020.11.020_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tcb.2015.10.010","article-title":"Caveolae: one function or many?.","volume":"26","author":"Cheng","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.apsb.2020.11.020_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tcm.2005.04.001","article-title":"Caveolae, lipid rafts, and vascular disease","volume":"15","author":"Li","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.apsb.2020.11.020_bib4","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1091\/mbc.12.8.2229","article-title":"Caveolin-1 expression negatively regulates cell cycle progression by inducing G0\/G1 arrest via a p53\/p21WAF1\/Cip1-dependent mechanism","volume":"12","author":"Galbiati","year":"2001","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2020.11.020_bib5","doi-asserted-by":"crossref","first-page":"16374","DOI":"10.1074\/jbc.272.26.16374","article-title":"Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth","volume":"272","author":"Engelman","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.11.020_bib6","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1242\/jcs.02894","article-title":"Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin","volume":"119","author":"Torres","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2020.11.020_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3892\/or.2014.3183","article-title":"Src\/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells","volume":"32","author":"Xu","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.apsb.2020.11.020_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.204","article-title":"Caveolin-1 abrogates TGF-\u03b2 mediated hepatocyte apoptosis","volume":"4","author":"Meyer","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2020.11.020_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2008.03.055","article-title":"Caveats of caveolin-1 in cancer progression","volume":"268","author":"Burgermeister","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib10","series-title":"Endocytosis and signaling","author":"Lamaze","year":"2018"},{"key":"10.1016\/j.apsb.2020.11.020_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biochi.2014.09.010","article-title":"Caveolin and cavin family members: dual roles in cancer","volume":"107","author":"Gupta","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.apsb.2020.11.020_bib12","doi-asserted-by":"crossref","first-page":"14932","DOI":"10.1021\/bi9613382","article-title":"Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae","volume":"35","author":"Fielding","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2020.11.020_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1083\/jcb.201003086","article-title":"Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation","volume":"191","author":"Hayer","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2020.11.020_bib14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bcp.2020.113959","article-title":"Drug uptake-based chemoresistance in breast cancer treatment","volume":"177","author":"Muley","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2020.11.020_bib15","first-page":"2747","article-title":"Caveolae-mechanosensitive membrane invaginations linked to actin filaments","volume":"128","author":"Echarri","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2020.11.020_bib16","series-title":"The caveolae membrane system","author":"Anderson","year":"1998"},{"key":"10.1016\/j.apsb.2020.11.020_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.biomaterials.2020.119902","article-title":"Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy","volume":"240","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2020.11.020_bib18","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.nanolett.9b03211","article-title":"Transcytosis of nanomedicine for tumor penetration","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2016.11.003","article-title":"Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors","volume":"64","author":"Wu","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.apsb.2020.11.020_bib20","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.4161\/cc.9.12.12048","article-title":"Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors","volume":"9","author":"Martinez Outschoorn","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2020.11.020_bib21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3892\/ol.2014.2385","article-title":"Value of caveolin-1 in cancer progression and prognosis: emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression","volume":"8","author":"Chen","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6075403","article-title":"Metabolic reprogramming of cancer associated fibroblasts: the slavery of stromal fibroblasts","author":"Avagliano","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.apsb.2020.11.020_bib23","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1111\/febs.13402","article-title":"Metabolic reprogramming of the tumour microenvironment","volume":"282","author":"Xing","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2020.11.020_bib24","doi-asserted-by":"crossref","first-page":"67626","DOI":"10.18632\/oncotarget.11759","article-title":"On metabolic reprogramming and tumor biology: a comprehensive survey of metabolism in breast cancer","volume":"7","author":"Penkert","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2020.11.020_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1053\/j.seminoncol.2017.10.004","article-title":"Metabolic coupling and the Reverse Warburg Effect in cancer: implications for novel biomarker and anticancer agent development","volume":"44","author":"Wilde","year":"2017","journal-title":"Semin Oncol"},{"key":"10.1016\/j.apsb.2020.11.020_bib26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4161\/cc.8.11.8544","article-title":"Towards a new \u201cstromal-based\u201d classification system for human breast cancer prognosis and therapy","volume":"8","author":"Witkiewicz","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2020.11.020_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4161\/cbt.7.8.6220","article-title":"Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy","volume":"7","author":"Mercier","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.apsb.2020.11.020_bib28","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2353\/ajpath.2009.080924","article-title":"Stromal cell expression of caveolin-1 predicts outcome in breast cancer","volume":"174","author":"Sloan","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2020.11.020_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cbt.10.2.11983","article-title":"Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers","volume":"10","author":"Witkiewicz","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.apsb.2020.11.020_bib30","article-title":"Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.11.020_bib31","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.4161\/cc.10.24.18551","article-title":"Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival","volume":"10","author":"Wu","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2020.11.020_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.4217","article-title":"Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse\u2014free survival and is functionally relevant to tumour progression","volume":"231","author":"Ayala","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.apsb.2020.11.020_bib33","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.4161\/cc.8.15.9116","article-title":"An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation","volume":"8","author":"Di Vizio","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2020.11.020_bib34","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13277-010-0081-1","article-title":"RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis","volume":"31","author":"Park","year":"2010","journal-title":"Tumor Biol"},{"key":"10.1016\/j.apsb.2020.11.020_bib35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/neuonc\/nos079","article-title":"Caveolin-1, caveolae, and glioblastoma","volume":"14","author":"Parat","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.apsb.2020.11.020_bib36","doi-asserted-by":"crossref","first-page":"21203","DOI":"10.1074\/jbc.M000321200","article-title":"The cyclin D1 gene is transcriptionally repressed by caveolin-1","volume":"275","author":"Hulit","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2020.11.020_bib37","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/sj.onc.1205300","article-title":"Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells","volume":"21","author":"Fiucci","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2020.11.020_bib38","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1158\/0008-5472.CAN-03-3941","article-title":"Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer","volume":"64","author":"Sunaga","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-#","article-title":"Hypermethylation of the caveolin-1 gene promoter in prostate cancer","volume":"46","author":"Cui","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.apsb.2020.11.020_bib40","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1541-7786.MCR-09-0255","article-title":"Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells","volume":"7","author":"Li","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bju.13224","article-title":"Prognostic value of Caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study","volume":"118","author":"Mathieu","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.apsb.2020.11.020_bib42","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1210\/mend.14.11.0553","article-title":"Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in\u00a0vivo: identification of a c-Src\/Cav-1\/Grb7 signaling cassette","volume":"14","author":"Lee","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2020.11.020_bib43","first-page":"3882","article-title":"Secreted caveolin-1 stimulates cell survival\/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer","volume":"61","author":"Tahir","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib44","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2009.080648","article-title":"Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell\/metastasis-associated gene signature","volume":"174","author":"Bonuccelli","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2020.11.020_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/ol.2016.5390","article-title":"Downregulation of caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil","volume":"13","author":"Li","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib46","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3892\/or.2015.4320","article-title":"Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1\/Akt\/NF-\u03baB pathway","volume":"34","author":"Zou","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.apsb.2020.11.020_bib47","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0014-5793(98)01354-4","article-title":"Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells","volume":"439","author":"Yang","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/1535-7163.MCT-17-0403","article-title":"Caveolae-mediated endocytosis as a novel mechanism of resistance to trastuzumab emtansine (T-DM1)","volume":"17","author":"Sung","year":"2018","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2020.11.020_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2020.00046","article-title":"Caveolin-1 promotes chemoresistance of gastric cancer cells to cisplatin by activating WNT\/\u03b2-catenin pathway","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2020.11.020_bib50","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jcp.29033","article-title":"Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway","volume":"235","author":"Liu","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2020.11.020_bib51","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1242\/jcs.00118","article-title":"Lipid rafts and the local density of ErbB proteins influence the biological role of homo-and heteroassociations of ErbB2","volume":"115","author":"Nagy","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2020.11.020_bib52","first-page":"71","article-title":"Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin multinational investigator study group","volume":"4","author":"Steven","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.apsb.2020.11.020_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2005.01.041","article-title":"Herceptin: mechanisms of action and resistance","volume":"232","author":"Nahta","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib54","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1038\/s41467-018-07608-w","article-title":"Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy","volume":"9","author":"Pereira","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2020.11.020_bib55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7150\/jca.6470","article-title":"Identification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells","volume":"4","author":"Sekhar","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.apsb.2020.11.020_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/mabs.22854","article-title":"Implications of receptor-mediated endocytosis and intracellular trafficking dynamics in the development of antibody drug conjugates","volume":"5","author":"Ritchie","year":"2013","journal-title":"mAbs"},{"key":"10.1016\/j.apsb.2020.11.020_bib57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/bcr3621","article-title":"Trastuzumab emtansine: mechanisms of action and drug resistance","volume":"16","author":"Barok","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib58","article-title":"Caveolin-1 dependent endocytosis enhances the chemosensitivity of HER-2 positive breast cancer cells to trastuzumab emtansine (T-DM1)","volume":"10","author":"Chung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.11.020_bib59","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1038\/s41598-018-22250-8","article-title":"Metformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cells","volume":"8","author":"Chung","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2020.11.020_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.11.020_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm1571","article-title":"Clathrin-and non-clathrin-mediated endocytic\u00a0regulation of cell signalling","volume":"6","author":"Le Roy","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2020.11.020_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/71889","article-title":"Synthetic DNA delivery systems","volume":"18","author":"Luo","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2020.11.020_bib63","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1242\/jcs.113.19.3509","article-title":"Isoforms of caveolin-1 and caveolar structure","volume":"113 Pt 19","author":"Fujimoto","year":"2000","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2020.11.020_bib64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biomaterials.2009.09.101","article-title":"The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents","volume":"31","author":"Sahay","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2020.11.020_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2009.02.003","article-title":"Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells","volume":"136","author":"Gabrielson","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.11.020_bib66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1517\/14656561003796562","article-title":"Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel","volume":"11","author":"Petrelli","year":"2010","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.apsb.2020.11.020_bib67","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijpharm.2016.06.008","article-title":"Cholesterol-modified poly (lactide-co-glycolide) nanoparticles for tumor-targeted drug delivery","volume":"509","author":"Lee","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.11.020_bib68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.actbio.2016.07.006","article-title":"Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells","volume":"42","author":"Sundaramoorthy","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2020.11.020_bib69","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1073\/pnas.1322356111","article-title":"Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae","volume":"111","author":"Voigt","year":"2014","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.apsb.2020.11.020_bib70","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.09.004","article-title":"Nab-paclitaxel for the treatment of triple-negative breast cancer: rationale, clinical data and future perspectives","volume":"50","author":"Schettini","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.apsb.2020.11.020_bib72","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2020.11.020_bib73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-physiol-021909-135833","article-title":"Regulation of endothelial permeability via paracellular and transcellular transport pathways","volume":"72","author":"Komarova","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.apsb.2020.11.020_bib74","doi-asserted-by":"crossref","first-page":"L823","DOI":"10.1152\/ajplung.00436.2006","article-title":"Molecular determinants of endothelial transcytosis and their role in endothelial permeability","volume":"293","author":"Predescu","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.apsb.2020.11.020_bib75","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/nn9012274","article-title":"Size and dynamics of caveolae studied using nanoparticles in living endothelial cells","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2020.11.020_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122581","article-title":"Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes","volume":"10","author":"Nicol\u00ec","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2020.11.020_bib77","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.2147\/IJN.S182621","article-title":"Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells","volume":"13","author":"Xu","year":"2018","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2020.11.020_bib78","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2020.02.086","article-title":"Involvement of caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomes","volume":"525","author":"Sakurai","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.11.020_bib79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-activatable polymer\u2013drug conjugate augments tumour penetration and treatment efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2020.11.020_bib80","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3109\/10717544.2015.1048488","article-title":"Albumin corona on nanoparticles\u2014a strategic approach in drug delivery","volume":"23","author":"Mariam","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2020.11.020_bib81","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1158\/0008-5472.CAN-17-0604","article-title":"Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy","volume":"77","author":"Chatterjee","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib82","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.canlet.2017.06.026","article-title":"Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma","volume":"403","author":"Borsoi","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2020.11.020_bib83","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3892\/ijmm.2012.1138","article-title":"Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor","volume":"30","author":"Gray","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.apsb.2020.11.020_bib84","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1186\/s12885-018-4936-y","article-title":"Caveolin-1 expression predicts efficacy of weekly Nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apsb.2020.11.020_bib85","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12253-011-9469-5","article-title":"Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome","volume":"18","author":"El Gendi","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.apsb.2020.11.020_bib86","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bjc.6604463","article-title":"Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype","volume":"99","author":"Elsheikh","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.apsb.2020.11.020_bib87","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers","volume":"174","author":"Witkiewicz","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2020.11.020_bib88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2010.10.041","article-title":"Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity","volume":"403","author":"Kim","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.11.020_bib89","doi-asserted-by":"crossref","first-page":"34039","DOI":"10.1021\/acsami.8b13707","article-title":"Multifunctional nanoparticles enable efficient oral delivery of biomacromolecules via improving payload stability and regulating the transcytosis pathway","volume":"10","author":"Zheng","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2020.11.020_bib90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/nn304218q","article-title":"Polymeric nucleic acid vehicles exploit active interorganelle trafficking mechanisms","volume":"7","author":"Fichter","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2020.11.020_bib91","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2174\/1381612822666151216151420","article-title":"Journey to the center of the\u00a0cell: current nanocarrier design strategies targeting biopharmaceuticals to the\u00a0cytoplasm and nucleus","volume":"22","author":"Munsell","year":"2016","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.apsb.2020.11.020_bib92","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin-and caveolae-mediated endocytosis in gene transfer mediated by lipo-and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2020.11.020_bib93","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/bit.26022","article-title":"Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes","volume":"113","author":"Ross","year":"2016","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.apsb.2020.11.020_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4172\/2157-7439.1000197","article-title":"The influence of drug loading on caveolin-1 mediated intracellular internalization of doxorubicin nanomicelles in\u00a0vitro","volume":"5","author":"Nehoff","year":"2014","journal-title":"J Nanomed Nanotechnol"},{"key":"10.1016\/j.apsb.2020.11.020_bib95","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2217\/nnm-2018-0334","article-title":"Mechanical cues modulate cellular uptake of nanoparticles in cancer via clathrin-mediated and caveolae-mediated endocytosis pathways","volume":"14","author":"Wei","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2020.11.020_bib96","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1002\/smll.201704245","article-title":"Liposomal treatment of cancer cells modulates uptake pathway of polymeric nanoparticles by altering membrane stiffness","volume":"14","author":"Xiang","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.apsb.2020.11.020_bib97","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.12.019","article-title":"Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly (lactic acid)-poly (ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells","volume":"159","author":"Dixit","year":"2018","journal-title":"Biomaterials"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520308200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520308200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:45:35Z","timestamp":1761929135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520308200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2211383520308200"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.11.020","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}